MedTrace Logo

The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients.

NCT07501988 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2026-04-08

No results posted yet for this study

Summary

Diabetes mellitus (DM) is a chronic disease characterized by impaired carbohydrate, protein, and lipid metabolism, resulting from a deficiency of insulin hormone secreted by the pancreas and/or the body's inability to utilize it even when sufficient insulin is secreted. As a frequently observed chronic disease, diabetes is a significant public health problem; if left uncontrolled, it can lead to serious complications and negatively impact quality of life.Individual management of treatment is crucial for successful treatment and glycemic control in diabetes. Due to the complexity of diabetes management related to insulin use, diabetics require greater self-care skills. Nurses play a crucial role in developing desired self-management behaviors in individuals with diabetes, supporting them, and meeting their needs.

Conditions

  • Diabete Mellitus
  • İnsulin Self-management

Interventions

BEHAVIORAL

Education

Patients will be informed about the importance of rotation and needle tip changes in diabetes management, and will receive training on injection technique, rotation technique, frequency of rotation, and the importance of needle tip changes using a mannequin. Patients will be reminded of the rotation plan and changes with each injection, and rotation training will be provided using a chart with visually colored rotation zones and written markings. Each patient consultation will last approximately 30-45 minutes. Patients will be given an educational booklet prepared with expert opinion. Communication with patients will be clear and understandable. Patients' questions will be answered after the training.

Sponsors & Collaborators

  • Ataturk University

    collaborator OTHER

  • Tokat Gaziosmanpasa University

    lead OTHER

Principal Investigators

  • Merve Ayşe Şahin · TOKAT GAZİOSMANPAŞA UNİVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-15
Primary Completion
2026-07-22
Completion
2026-07-22

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07501988 on ClinicalTrials.gov